S. Hayley

504 total citations
12 papers, 391 citations indexed

About

S. Hayley is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, S. Hayley has authored 12 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in S. Hayley's work include Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). S. Hayley is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). S. Hayley collaborates with scholars based in United States. S. Hayley's co-authors include Elizabeth M. Jaffee, Evanthia T. Roussos Torres, Kayla Cruz, Blake Scott, Brian J. Christmas, Todd D. Armstrong, Skylar Woolman, Christine I. Rafie, Alexander C. Hopkins and Roisín M. Connolly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

S. Hayley

12 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Hayley United States 6 198 179 167 103 39 12 391
Magdalena Hinterbrandner Switzerland 6 145 0.7× 117 0.7× 105 0.6× 101 1.0× 21 0.5× 7 270
Eva Grundschober Austria 5 110 0.6× 130 0.7× 90 0.5× 83 0.8× 56 1.4× 6 277
Sarah S. Donatelli United States 6 143 0.7× 335 1.9× 206 1.2× 142 1.4× 37 0.9× 7 522
Yumiko Higuchi Japan 10 167 0.8× 166 0.9× 92 0.6× 45 0.4× 54 1.4× 30 305
Jing Christine Ye United States 7 139 0.7× 61 0.3× 89 0.5× 82 0.8× 24 0.6× 20 262
Kathrin Meinhardt Germany 5 207 1.0× 241 1.3× 119 0.7× 37 0.4× 14 0.4× 8 377
Leutz Buon United States 10 133 0.7× 56 0.3× 241 1.4× 113 1.1× 16 0.4× 28 368
Simon Renders Germany 9 48 0.2× 113 0.6× 121 0.7× 126 1.2× 44 1.1× 17 295
Yadira M. Soto-Feliciano United States 4 75 0.4× 85 0.5× 122 0.7× 33 0.3× 35 0.9× 7 240
Parimala Sonika Godavarthy Germany 8 62 0.3× 61 0.3× 95 0.6× 134 1.3× 53 1.4× 10 249

Countries citing papers authored by S. Hayley

Since Specialization
Citations

This map shows the geographic impact of S. Hayley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hayley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hayley more than expected).

Fields of papers citing papers by S. Hayley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Hayley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hayley. The network helps show where S. Hayley may publish in the future.

Co-authorship network of co-authors of S. Hayley

This figure shows the co-authorship network connecting the top 25 collaborators of S. Hayley. A scholar is included among the top collaborators of S. Hayley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Hayley. S. Hayley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hayley, S., Evanthia T. Roussos Torres, John-William Sidhom, et al.. (2019). A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell–Mediated Anticancer Activity. Cancer Immunology Research. 7(3). 428–442. 94 indexed citations
2.
Christmas, Brian J., Christine I. Rafie, Alexander C. Hopkins, et al.. (2018). Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs. Cancer Immunology Research. 6(12). 1561–1577. 161 indexed citations
3.
Hutzen, Brian, Chun‐Yu Chen, Pin-Yi Wang, et al.. (2018). Abstract A08: TGFβb inhibition improves oncolytic herpes viroimmunotherapy in murine models of rhabdomyosarcoma. Cancer Research. 78(19_Supplement). A08–A08. 1 indexed citations
4.
Hayley, S., Evanthia T. Roussos Torres, Tara M. Robinson, et al.. (2018). Abstract 4936: Combination CD40 agonist and PD-1 antagonist antibody therapy enhances vaccine induced T cell responses in non-immunogenic cancers. Cancer Research. 78(13_Supplement). 4936–4936. 3 indexed citations
5.
Hayley, S., Li Li, Alice Can Ran Qin, et al.. (2017). Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase–Driven Leukemias and Other Malignancies. Cancer Research. 77(20). 5554–5563. 32 indexed citations
6.
Hayley, S., Evanthia T. Roussos Torres, Brian J. Christmas, et al.. (2017). Abstract 2613: Combination agonist and antagonist antibody therapy enhances vaccine induced T cell responses in non-immunogenic cancers. Cancer Research. 77(13_Supplement). 2613–2613. 1 indexed citations
7.
Hayley, S., Sarah Greenblatt, Amy S. Duffield, et al.. (2016). All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo. Blood. 127(23). 2867–2878. 43 indexed citations
8.
Li, Li, S. Hayley, Alice Can Ran Qin, et al.. (2016). Signaling Adaptation to TKI Treatment Reactivates ERK Signaling in FLT3/ITD Leukemia. Blood. 128(22). 33–33. 2 indexed citations
9.
10.
11.
Hayley, S., Bao Nguyen, Amy S. Duffield, et al.. (2014). FLT3 Kinase Inhibitor TTT-3002 Overcomes Both Activating and Drug Resistance Mutations in FLT3 in Acute Myeloid Leukemia. Cancer Research. 74(18). 5206–5217. 25 indexed citations
12.
Li, Li, et al.. (2013). FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice. Proceedings of the National Academy of Sciences. 110(52). 21113–21118. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Hinterbrandner Breakdown of academic impact, for papers by Eva Grundschober Breakdown of academic impact, for papers by Sarah S. Donatelli Breakdown of academic impact, for papers by Yumiko Higuchi Breakdown of academic impact, for papers by Jing Christine Ye Breakdown of academic impact, for papers by Kathrin Meinhardt Breakdown of academic impact, for papers by Leutz Buon Breakdown of academic impact, for papers by Simon Renders Breakdown of academic impact, for papers by Yadira M. Soto-Feliciano Breakdown of academic impact, for papers by Parimala Sonika Godavarthy
Rankless by CCL
2026